Bio/Pharma News

Nov 13, 2017
By Pharmaceutical Technology Editors
The company has appointed Albert Bourla, PhD, as its new COO.
Nov 10, 2017
By Pharmaceutical Technology Editors
The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.
Nov 10, 2017
By Pharmaceutical Technology Editors
The EMA’s Committee for Medicinal Products for Human Use has recommended marketing authorization approval for AstraZeneca’s benralizumab, a monoclonal antibody for treating severe asthma.
Nov 03, 2017
By Pharmaceutical Technology Editors
The agency gave Breakthrough Therapy Designation to GSK’s GSK2857916 monotherapy for the treatment of patients with multiple myeloma who have failed at least three prior lines of therapy.
Nov 02, 2017
By Pharmaceutical Technology Editors
The companies will collaborate to develop and manufacture Grid’s lead therapeutic candidate for the treatment of solid tumors.
Nov 01, 2017
By Pharmaceutical Technology Editors
Eli Lilly was awarded the 2017 FOYA Overall Winner for its continuous direct compression manufacturing installation projects.
Oct 27, 2017
By Pharmaceutical Technology Editors
AbbVie will pay a $205-million upfront payment and have the option to develop and commercialize two antibody targets globally.
Oct 27, 2017
By Pharmaceutical Technology Editors
As part of the $900-million deal, Incyte will pay $150 million upfront to develop and commercialize an anti-PD-1 drug candidate from biopharmaceutical company, MacroGenics.
Oct 27, 2017
By Pharmaceutical Technology Editors
The vaccine is approved for the prevention of shingles in adult patients aged 50 years and older.
Oct 26, 2017
By Pharmaceutical Technology Editors
The company’s board of directors has appointed Aron Knickerbocker as the new president and CEO to succeed Lewis Williams, MD, PhD, effective Jan. 1, 2018.
native1_300x100
lorem ipsum